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Foetal and adult liver 6-phosphofructo-2-kinase (PFK-2) were purified by identical protocols. The native molecular
masses of both enzymes were determined by gel filtration and were 89.1 and 100.0 kDa respectively. No differences were
found in SDS/PAGE in 10 %-acrylamide gel (55 kDa per subunit). The kinetic properties displayed by both enzymes were
similar, except for the sensitivity to inhibition by sn-glycerol 3-phosphate. Foetal PFK-2 was a good substrate for
phosphorylation by cyclic AMP-dependent protein kinase and protein kinase C, whereas the adult enzyme was
phosphorylated only by cyclic AMP-dependent protein kinase. However, the phosphorylation affected only the kinetic
properties of the adult enzyme, suggesting the presence in both enzymes of different sites of phosphorylation by cyclic
AMP-dependent protein kinase. These differences in primary structure were consistent with the distinct chromatographic
profiles of the phosphopeptides after digestion of the protein with CNBr. Western-blot analysis with antibodies specific
for the N-terminal region of the liver-type PFK-2 poorly recognized the foetal enzyme, suggesting that both enzymes
differ at least in the N-terminal sequence.
INTRODUCTION
Transition from the foetal to the neonatal period is ac-
companied by important changes in liver carbohydrate metab-
olism. These changes are induced by hormonal and nutritional
factors [1] and by modifications in the expression pattern of
enzymes and tissue-specific isoenzymes [2-4].
One of the relevant factors in the control of the glycolytic and
gluconeogenic fluxes in liver is the change in fructose 2,6-
bisphosphate (Fru-2,6-P2) concentration [5]. Foetal hepatocytes
contain a form of 6-phosphofructo-2-kinase (PFK-2) that ex-
hibits marked differences from the adult form in its regulatory
properties, mainly the lack of glucagon-dependent inactivation
of the enzyme, which occurs for the adult tissue [6]. Accordingly,
incubation of foetal PFK-2 with the catalytic subunit of the
cyclic AMP-dependent protein kinase did not produce changes
in the enzyme activity. Using cultured hepatocyes from 22-day
foetuses we showed that incubation with glucagon for periods
longer than 45 min elicited the appearance of the glucagon-
responsive enzyme [7]. Moreover, a PFK-2 that behaved like the
adult enzyme was detected 3 h after birth as a result of the
hypoglycaemia and glucagonaemia of this period [7]. In addition,
exposure of foetal hepatocytes to phorbol myristate acetate
increased the PFK-2 activity and Fru-2,6-P2 concentration,
whereas this response was absent in adult cells [8]. These data
strongly suggest the existence of a different isoenzyme of PFK-
2 in the foetal period that exhibits some kinetic properties similar
to those reported for the bovine heart or rat hepatoma-tumour-
cell (HTC) enzymes [9-11].
There is clear evidence for the existence of at least two PFK-
2/fructose-2,6-bisphosphatase (FBPase-2) isoenzymes: the liver
(L) and the muscle (M) isoenzyme, which are the products of one
gene by alternative use of two promoters. There are two mRNAs
for this bifunctional enzyme: one mRNA is 2.1 kb long and
encodes the L isoenzyme, and the other mRNA is 1.9 kb long
and it encodes a protein that displays properties of the M
isoenzyme [12,13]. A third 6.8 or 4 kb mRNA typical of cardiac
tissue has been reported [14,15]. In rat hepatoma cells, the PFK-
2/FBPase-2 has kinetic, antigenic and regulatory properties that
differ from those found in liver. It has been suggested that HTC-
cell PFK-2 is the foetal form of the enzyme [11,16].
In the present paper, we report further differences between
adult and foetal liver PFK-2/FBPase-2 regarding molecular
mass, phosphorylation by cyclic AMP-dependent protein kinase
and protein kinase C, immunoreactivity and a different peptide
composition as deduced after CNBr cleavage.
EXPERIMENTAL
Materials
Pregnant Albino Wistar rats (300-350 g) fed on a standard
laboratory diet were killed for the experiments between 09:00
and 10:00 h. Gestational age was confirmed by standard criteria
[17]. Newborn rats were delivered by caesarean section in the
morning of day 22 of gestation. Livers were removed and stored
in liquid N2.
Substrates, coenzymes and enzymes were obtained from
Boehringer (Mannheim, Germany) or Sigma (St. Louis, MO,
U.S.A). Standard analytical-grade laboratory reagents were
purchased from Merck (Darmstadt, Germany). Electrophoresis
reagents were from Bio-Rad (Richmond, CA, U.S.A.). Radio-
chemicals were purchased from Amersham International (Amer-
sham, Bucks, U.K.).
Enzyme purification
PFK-2 was purified from adult and foetal rat liver (300-400 g
of tissue) by the same procedure [18]. Livers were homogenized
with an Ultra-Turrax instrument in 4 vol. (v/w) of buffer A
[20 mM-potassium phosphate, 1 mM-EDTA, 2 mM-dithiothreitol
(DTT), 100 mM-KCl, 0.5 mM-phenylmethanesulphonyl fluoride,
0.1 mM-fructose 6-phosphate, pH 7.4 at 4 °C]. After centri-
fugation (10000 g for 20 min), the supernatants were filtered
through glass wool and fractionated with poly(ethylene glycol)
7000. The 6-15 %-poly(ethylene glycol) pellet fractions were
resuspended in one-fourth of the homogenate volume, in buffer
A. The fractions were then applied to a column (5 cm x 25 cm) of
DE52 DEAE-cellulose equilibrated with buffer A. After washing
the column with buffer A until the eluate was free of protein
Abbreviations used: Fru-2,6-P2, fructose 2,6-bisphosphate;
(EC 2.7.1.105); DTT, dithiothreitol.
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(monitored by the A280), PFK-2 was eluted with a linear gradient
of KCI (in buffer A, 100-600 mM-KCl). Fractions containing
PFK-2 activity were pooled and applied to a column (2.5 cm x
15 cm) of Blue Sepharose CL-6B equilibrated with buffer B
[15 mM-Hepes, 2 mM-DTT, 1 mM-EDTA, 1 mM-potassium
phosphate, 100 mM-KCI, 0.1 mM-fructose 6-phosphate, 0.5 mM-
phenylmethanesulphonyl fluoride, 20% (v/v) glycerol at pH 7.4].
The column was washed with buffer B, followed by buffer B
containing 400 mM-KCl (buffer C), until the protein concen-
tration in the eluate was negligible. PFK-2 was eluted (at 2.5 mM)
with a linear gradient of 0-15 mM-MgATP in buffer C. The PFK-
2 enriched fractions were pooled, dialysed and concentrated by
freeze-drying. The enzymes were resuspended in buffer D (10 mm-
Hepes, 1 mM-DTT, 1 mM-potassium phosphate, 0.1 mM-fructose
6-phosphate, 50% glycerol, at pH 7.4) and stored frozen at
-80 'C. Samples of the frozen stored enzyme were thawed and
further purified by gel filtration through a column (2.6 cm x
87 cm) of Sephacryl S-200 equilibrated with 10 mM-potassium
phosphate/ I mM-DTT/100 mM-NaCl/2 % glycerol, pH 7.4. The
yield of the enzyme purification was about 20 %. The purity of
the preparations was determined by SDS/PAGE in 10%-
acrylamide gels. Proteins were detected by Coomassie Blue [19].
To determine the molecular mass of PFK-2 from adult or
foetal liver, the purified enzymes (25 ug) were analysed by
SDS/PAGE (10 %-acrylamide gel), or applied to a Zorbax GF-
250 h.p.l.c. column (0.9 cm x 25 cm) equilibrated with 200 mm-
sodium phosphate/0.5 mM-DTT/0.005 % NaN3 at pH 7.0 and
with thyroglobulin, catalase, aldolase, BSA and myoglobin as
calibration standards. The elution was monitored by the A280.
Fractions were collected every 4 s and assayed for PFK-2 activity.
Protein kinase C was purified from bovine brain after chromat-
ography on DEAE-cellulose DE52, phenyl-Sepharose and
protamine-agarose as described elsewhere [20,21]. The specific
activity of this preparation was 0.8,mol of [32P]phosphate
incorporated into histone HI/min per mg of protein.
Assay of enzyme activities
Purified PFK-2 activity was measured as described by Rider et
al. [18]. The 'active' form of PFK-2 was measured at pH 6.6 in
the presence of 1 mM-fructose 6-phosphate. The total activity
was measured at pH 8.5 with 5 mM-fructose 6-phosphate [22].
The sensitivity of PFK-2 activity to inhibition by sn-glycerol 3-
phosphate was determined at pH 7.1 in the presence of 0.1 mM-
fructose 6-phosphate and 0.5 mM-MgATP [18]. The affinity of
PFK-2 for fructose 6-phosphate was determined at pH 7.1 in the
presence of 5 mM-MgATP. The affinity ofMgATP was measured
at pH 7.1 by using 1 mM-fructose 6-phosphate.
Protein phosphorylation
PFK-2 (50 ,ug) was incubated at 30 'C for 30 min in a final
volume of 0.25 ml containing 100 mM-KCI, 5 mM-MgCl2, 1 mM-
DTT, 1 mM-potassium phosphate, 5 mM-MgATP and 20 mm-
Hepes at pH 7.4 with 0.1 m-unit of catalytic subunit of cyclic
AMP-dependent protein kinase. Incubations with protein kinase
C (0.1Im-units) included 40 ug of phosphatidylserine/ml and
0.2 mM-CaCl2. Samples (20 ,ll) were used to assay PFK-2 activity
at pH 6.6 and 8.5 as previously indicated. One unit of catalytic
subunit of cyclic AMP-dependent protein kinase was defined as
the activity that incorporates 1 ,umol of phosphate into histone
H2A/min at 30 'C. One unit of protein kinase C was defined as
the amount of enzyme that incorporates I /tmol of phosphate
into histone HI/min at 30 'C.
When the incorporation of [32P]phosphate into the enzyme
was measured, purified PFK-2 both from adult and foetal rat
liver (100 ,ug) was incubated at 30 °C for 30 min with 0.1Im-unit
of catalytic subunit of cyclic AMP-dependent protein kinase in an
assay mixture containing 50 mM-Tris/phosphate, 0.1 mM-EDTA,
2 mM-MgCl2 and 2 mM-DTT at pH 7.4 (final volume of 0.2 ml).
Reactions were initiated with 200 ,M-[y-32P]ATP (700 c.p.m./
pmol) and samples (20 ,ul) were collected at the indicated times
for measurement of [32P]phosphate incorporation into trichloro-
acetic acid-insoluble material [18]. After incubation for 30 min,
the remaining reaction mixture was denatured with 20,ul of
Laemmli [19] sample buffer and used for SDS/PAGE.
Incubations with protein kinase C (0.1Im-unit) were carried
out in an assay containing 50 mM-Hepes, pH 7.4, 15 mM-fl-
mercaptoethanol, 0.25 mM-CaCl2, 40 ,ug of phosphatidylserine/
ml, 8 mM-magnesium acetate and 200 guM-[y-32P]ATP
(700 c.p.m./pmol) in a total volume of 0.2 ml. Proteins were
detected with Coomassie Blue staining before gel drying and
autoradiography.
The endogeneous phosphoenzyme present in purified PFK-2
was determined after incubation of the enzyme (100,ug) with
immobilized alkaline phosphatase-agarose (2 units; one unit
hydrolysed 1 ,umol of p-nitrophenyl phosphate/min at pH 10)
for 30 min at 30 °C in 20 mM-Tris, pH 8.9, followed by the
phosphorylation with the appropriated protein kinase. The
percentage of phosphoenzyme was calculated by subtracting
the radioactivity incorporated after treatments with alkaline
phosphatase from that of untreated samples.
Antibodies against adult rat liver PFK-2/FBPase-2
An antibody specific against a decapeptide corresponding to
the N-terminus of adult liver PFK-2, previously described [16],
was kindly provided by Professor L. Hue and Professor G. G.
Rousseau, Lovain Medical School, Brussels, Belgium.
Western-blot analysis
Foetal and adult liver purified PFK-2 were electrophoretically
separated in SDS/PAGE as described by Laemmli [19]. After the
run, the gel was equilibrated in transfer buffer [25 mM-Tris,
192 mM-glycine, 20% methanol) and proteins were electro-
phoretically transferred (0.5 mA/cm2, 15 h) to nitrocellulose
membranes [23]. The antigen (PFK-2) was detected by a specific
primary antibody. Bound antibody was detected by a
peroxidase/anti-peroxidase complex revealed by oxidation of 4-
chloro-l-naphthol to a violet product. Quantification of the
peroxidase reaction was performed in a densitometer (E-C
Apparatus Corp.).
Thiol modification of PFK-2 activity
The purified enzymes (50 ,tg) were reduced with fresh DTT
(2 mm final concn.) and applied to a h.p.l.c. Zorbax GF-250
column equilibrated with 50 mM-sodium phosphate (pH 7.1) to
remove the thiol protectants and were immediately alkylated
with a fresh solution of 1.5 mM-iodoacetamide. At the indicated
times, samples (20 ,ul) were mixed with 80 ,u of 50 mM-DTT in
order to stop the alkylation and maintained at 4 'C. The mixture
was assayed for PFK-2 activity at 5 mm- or 50,uM-fructose 6-
phosphate in the presence of 5 mM-MgATP and 5 mM-phosphate,
as previously described.
CNBr cleavage of PFK-2/FBPase-2
The purified enzymes (250 ,ug) were reduced with fresh DTT
(2 mm final concn.) and, after removal of the thiol protectants by
h.p.l.c. gel filtration, the proteins were immediately alkylated
with a fresh solution of 1.5 mM-iodo[1-14C]acetamide (20 d.p.m./
pmol) at 30 'C for 1 h. At the indicated times, samples (10 dil)
were stopped with 100 ,l of 100 mM-DTT, followed by addition
of 1 ml ofice-cokd trichloroacetic acid (5 %, w/v). After filtration
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on GF/C filters (Whatman) the radioactivity was measured. At
the end of the incubation period the remaining reaction was
stopped with 200 ,ul of 100 mM-DTT and 1 ml of ice-cold 10 %
trichloroacetic acid and centrifuged in a Eppendorf Microfuge
for 15 min. The pellet was resuspended in 1 vol. (original) of
700% (v/v) formic acid and solid CNBr was added to a final
concentration of 2 mg/ml. The tube was flushed with N2 and
incubated for 24 h at room temperature. After vacuum drying
of the tubes, the peptides were resuspended in 100 4u1 of the
medium used for the resolution from the h.p.l.c. column (see
below). A similar protocol, but in the presence of 1 mM-DTT, was
used for CNBr digestion of PFK-2 after phosphorylation either
by the catalytic subunit of the cyclic AMP-dependent protein
kinase or by protein kinase C as previously described. The
solution containing the CNBr fragments was applied to a
Brownlee (25 cm x 0.46 cm) reverse-phase column (Spheri-5 RP8
5 /LM) and resolved by an isocratic gradient of 30% acetonitrile/
70% of a mixture of 0.6 % acetic acid and 0.003 % triethylamine
at a flow rate of 1 ml/min, by using a h.p.l.c. system. Injection of
mixtures containing foetal and adult peptides were used to assess
the accuracy of the column resolution. The eluted peptides were
detected at 280 nm and by counting the emerging radioactivity.
Protein concentration was determined by the Bradford method
[24], with bovine serum albumin as a standard.
RESULTS
Enzyme characterization
PFK-2 from foetal and adult rat liver was purified by poly-
(ethylene glycol) fractionation, DEAE-cellulose DE52 and Blue
Sepharose chromatography followed by gel filtration on a Zorbax
GF-250 h.p.l.c. column. The physical behaviour of both enzymes
throughout the purification procedure was very similar, except
for the small difference in salt concentration needed to elute the
enzyme from the DEAE-cellulose DE52 column (300 mm- and
375 mM-KCl for adult and foetal enzyme respectively). The
native molecular masses determined for the foetal and adult
enzymes were 89.1 and 100.0 kDa respectively (Fig. la). Gel
filtration on Sephacryl S-200 gave the same results. However, the
subunit molecular mass deduced from the relative mobility on
SDS/PAGE (10 %-acrylamide gels) was 55 kDa for both enzymes
(Fig. lb). The more relevant kinetic properties of purified foetal
and adult PFK-2 are shown in Table 1. No significant differences
between the enzymes were observed in the affinity for fructose 6-
phosphate and ATP. However, in agreement with previous work
[6], a marked difference was observed in the inhibition by sn-
glycerol 3-phosphate; the apparent K1 values were 2.7 + 0.3 and
0.15+ 0.02 mm respectively for foetal and adult PFK-2. The
specific activities of both enzymes were 80 + 11 and 55 + 9 m-
units/mg of protein for foetal and adult PFK-2.
PFK-2 phosphorylation
To analyse further the nature of the foetal and adult PFK-2,
the purified enzymes were incubated with immobilized alkaline
phosphatase before being assayed as substrates of the catalytic
subunit of the cyclic AMP-dependent protein kinase and of
protein kinase C. In addition to this, the effect of this phosphoryl-
ation on the kinetic properties of both enzymes was measured.
As shown in Fig. 2(a), incubation of foetal liver PFK-2 with
cyclic AMP-dependent protein kinase resulted in the phosphoryl-
ation of the enzyme, but this covalent modification was not
followed by changes either in the affinity for fructose 6-phosphate
(results not shown) or in the ratio between the active and total
enzyme determined by the relative activities at pH 8.5 and
pH 6.6 (1.2 and 0.8 for the phospho- and dephospho-enzyme
Vol. 281
7.5 r
0
uo
E
c,
.5ua)
0
o
(a)
6.7 1
5.9 - Adult
**
5.1 F
4.3F
3.5
6.0 8.0 10.0
Retention time (min)
F A (b)
(kDa)
66
45
36
12.0
Fig. 1. Determination of the molecular mass of PFK-2
(a) Samples of foetal or adult PFK-2 (25 ug) were injected into a
h.p.l.c. Zorbax GF-250 column. The A280 was recorded and fractions
(4s) were collected to assay PFK-2 activity. The calibration standards
were thyroglobulin (669 kDa), catalase (232 kDa), aldolase
(158 kDa), BSA (67 kDa) and myoglobin (17 kDa). Results are
expressed as means + S.E.M. of the retention times at peak values for
5-7 different injections: ** significantly different from adult enzyme
(P < 0.05). (b) SDS/PAGE (10 %-acrylamide gel) analysis of foetal
(F) and adult (A) PFK-2.
respectively). As has been well established [25], the adult liver
enzyme processed in parallel with the foetal one was also
phosphorylated by the cyclic AMP-dependent protein kinase,
but exhibited kinetic changes in the activity ratio at pH 8.5/
pH 6.6 (1.2 and 3.5 for the dephospho- and phospho-enzyme
respectively; results not shown). In addition to the cyclic AMP-
dependent protein kinase, foetal PFK-2 was also incubated with
purified bovine brain protein kinase C. As shown in Fig. 2(a), the
foetal enzyme was phosphorylated by protein kinase C. However,
the phosphoenzyme did not show changes in the activity ratio at
pH 8.5 and pH 6.6. The stoichiometry of the phosphorylation of
foetal PFK-2 by cyclic AMP-dependent protein kinase and
protien kinase C was 0.95 mol of [32P]phosphate/mol of enzyme
subunit (Fig. 2b). Consistent with previous work [9], the adult
enzyme was not phosphorylated by protein kinase C (results not
shown).
When the foetal enzyme was incubated with protein kinase C
after phosphorylation with cyclic AMP-dependent protein kinase,
an additional 0.9 mol of phosphate was incorporated per mol of
subunit, suggesting the presence of two different phosphorylation
sites per enzyme subunit (see Fig. 6). Foetal PFK-2 phosphoryl-
ated by both kinases did not exhibit kinetic changes in the affinity
for fructose 6-phosphate or in the maximal activity.
Table 1. Summary of kinetic properties of purified foetal and adult rat liver
PFK-2
The enzyme activity was assayed at pH 7.1 in the presence of 1 mM-
potassium phosphate. The inhibition by sn-glycerol 3-phosphate was
measured with 0.1 mM-fructose 6-phosphate and 0.5 mM-MgATP.
Results are means + S.E.M. of duplicates from three different enzyme
purifications.
Foetal Adult
Km for fructose
6-phosphate (,uM)
Km for ATP (fZM)
K, for sn-glycerol
3-phosphate (mM)
Sp. activity (m-units/
mg of protein)
44+6
195 ± 30
> 2.7
80+ 11
47 + 7
190+23
0.15+0.02
55 + 9
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Fig. 2. Phosphorylation of PFK-2 by the catalytic subunit of the cyclic AMP-dependent protein kinase and by protein kinase C
(a) Purified foetal PFK-2 (100 ,ug) was incubated in parallel either with 0.1 rm-unit of cyclic AMP-dependent protein kinase or 0.1 rm-unit of protein
kinase C for 30 min at 30 °C in the presence of 200 1sM-[y-32P]ATP (700 c.p.m./pmol). Samples were collected to determine the activity ratio at
pH 8.5/pH 6.6, the stoichiometry of the reaction and the identity of the phosphoenzyme. (a) Autoradiography of foetal PFK-2 phosphorylation:
lane 1, PFK-2 plus 0.1 rm-unit of cylic AMP-dependent protein kinase; lane 2, PFK-2 in the absence of protein kinase; lane 3, PFK-2 plus protein
kinase C in the presence of Ca2' and phospholipids. (b) Time course of phosphorylation of foetal liver PFK-2 by cyclic AMP-dependent
protein kinase (0) and by protein kinase C (0).
Treatment of adult and foetal PFK-2 with alkaline
phosphatase-agarose before phosphorylation with protein kin-
ases showed that the amount of phosphoenzyme in the purified
PFK-2 was about 10-12% when phosphorylated by cyclic AMP-
dependent protein kinase, whereas no changes were observed in
the case of phosphorylation of the foetal enzyme by protein
kinase C.
Western-blot analysis of PFK-2
The differences in the response to cyclic AMP-dependent
protein kinase and protein kinase C by both enzymes
suggested the existence of two isoenzymes in foetal and adult
liver. As shown in Fig. 3, Western-blot analysis of purified foetal
and adult PFK-2 using a specific antibody against a decapeptide
corresponding to the N-terminus of the adult liver enzyme
revealed a different recognition pattern for both proteins. The
staining of the adult enzyme is about 6-fold higher than for the
40
;- 20
c:
0.3 0.7 1.7 0.3 0.5 1.3
Protein (jig/lane)
Fig. 3. PFK-2 characterization by a liver-type specific antibody
Purified foetal (U) and adult (aI) PFK-2 were submitted to Western-
blot analysis and recognition by an antibody raised against a
decapeptide specific for the adult liver enzyme. The peroxidase-
coupled reaction was quantified in a densitometer and the relative
colour intensities were expressed as percentages of the total signal.
foetal protein, suggesting a different N-terminal sequence for
each protein.
Effect of thiol-group modification on PFK-2 activity
Iodoacetamide and related thiol-modifying reagents have
important effects on PFK-2 activity [26,27]. Alkylation of purified
adult liver PFK-2 with iodoacetamide produced a 10-20-fold
decrease in the affinity for fructose 6-phosphate, and a 10-fold
increase in the Vm.. of the enzyme [27]. To study the effect of
alkylation on PFK-2 activity, both foetal and adult liver enzymes
were incubated with 1.5 mM-iodoacetamide and samples were
collected and assayed for PFK-2 activity at saturating and sub-
saturating concentrations of fructose 6-phosphate. As shown in
Fig. 4(a), a 4-fold increase in Vm.. of the adult enzyme was
observed, whereas only a 2-fold increase was evidenced for the
foetal enzyme. In both cases, a clear and parallel decrease in the
affinity for fructose 6-phosphate was observed.
The time course of incorporation of iodo[l-_4C]acetamide into
foetal and adult PFK-2 is shown in Fig. 4(b). In both cases a
maximum of 3-4 readily accessible cysteine residues per molecule
of PFK-2 subunit may be alkylated. The apparent correlation
between the mol of acetamide incorporated/mol of enzyme
subunit and the activation of the kinase for the adult enzyme
should be noted. However, although the kinetics of the in-
corporation of acetamide into PFK-2 is similar for both enzymes,
the maximal activation of the foetal enzyme is obtained at lower
stoichiometries of alkylation than for the adult enzyme (Fig. 4).
CNBr peptides of PFK-2
To obtain further structural information about the foetal and
adult PFK-2, the purified enzymes were alkylated with iodo[l-
14C]acetamide, proteolysed with CNBr, and the resulting peptides
were analysed on a h.p.l.c. reverse-phase column. As shown in
Fig. 5, only one ['4C]carboxyamidomethylated fragment was
evident for adult PFK-2, whereas two labelled peptides were
observed for the foetal enzyme. From the specific radioactivity
of iodoacetamide and the analysis of the relative intensity of the
radiolabelled peaks, it can be calculated that for the foetal
enzyme the relative number of cysteine residues present in the
peptides eluted at 3.8 and 8.2 min would be 1.1 and 2.5, whereas
for the adult enzyme the peak eluted at 8.6 min corresponds to
3 residues.
In addition to alkylation, foetal and adult PFK-2 were
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Fig. 4. Time course of PFK-2 alkylation
Foetal (@, A) and adult (O, A) PFK-2 were processed by h.p.l.c. gel filtration to remove DTT, and were immediately alkylated with 1.5 mM-
iodoacetamide. (a) Effect of alkylation on PFK-2 activity assayed with 5 mM- (0, 0) or 50,M- (A, A) fructose 6-phosphate. (b) Incorporation
of iodo[l-14C]acetamide into foetal (a) and adult (0) PFK-2. Results are means + S.E.M. of three different assays (a) or means of duplicate (b).
phosphorylated by the catalytic subunit of the cyclic AMP-
dependent protein kinase in the presence of [y-32P]ATP, followed
by digestion with CNBr. Fig. 6(a) shows the elution profile of the
CNBr peptides on a h.p.l.c. reverse-phase column for both
proteins. As expected from the stoichiometry of the phosphoryl-
ation reaction, only one [32P]phosphate-labelled peak was evident
for each protein; however, the phosphopeptides emerged with
-d
cu
:tr0
~0
'a
x
different retention times (3.24 and 4.0 min for adult and foetal
peptides respectively), indicating that the phosphorlylation sites
were located in two different peptides.
When samples of foetal PFK-2 phosphorylated by cyclic
AMP-dependent protein kinase were submitted to phosphoryl-
ation by protein kinase C and digested with CNBr, two phospho-
peptides were evident (retention times 4.0 and 6.3 min respect-
6
Retention time (min)
12
Fig. 5. Identificationiof carboxyamidomethylated peptides of PFK-2 after CNBr proteolysis
Foetal ( ) and adult (----) PFK-2 (250 jug) were reduced with 2 mM-DTT, and processed through a h.p.l.c. Zorbax GF-250 gel-filtration
column to remove the remaining DTT, followed by incubation with 1.5 mM-iodo[I- 4C]acetamide. After digestion with CNBr in 70% (v/v) formic
acid and vacuum drying, samples were resuspended in h.p.l.c. elution medium and injected (25 ,ul) into a h.p.l.c. reverse-phase column and the
radioactivity was measured. Insets show the peptide elution profile of foetal (a) and adult (b) PFK-2.
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Fig. 6. Identification of phosphopeptides of PFK-2 after CNBr proteolysis
(a) Foetal ( ) and adult (----) PFK-2 were incubated in the presence of 0.1 rm-unit of the catalytic subunit ofthe cyclic AMP-dependent protein
kinase, followed by digestion with CNBr in 70% formic acid. Samples (25 ltl) were injected into a h.p.l.c. reverse-phase column and the
radioactivity was measured. (b) Foetal PFK-2 was phosphorylated by protein kinase C after incubation for 30 min with cyclic AMP-dependent
protein kinase, followed by digestion with CNBr. Samples were injected into a h.p.l.c. reverse-phase column and the radioactivity was measured.
ively), indicating the presence of two different phosphorylation
sites in the protein (Fig. 6b).
DISCUSSION
This report presents further evidence suggesting that PFK-
2/FBPase-2 from foetal rat liver is different from the adult
enzyme. The purification procedure described for the liver enzyme
was suitable for the purification of foetal PFK-2. The specific
activity of the foetal enzyme was about 1.5 times that for the
adult enzyme. However, the FBPase-2 activity of the foetal
enzyme was lower than 0.4 m-unit/mg of protein, in contrast
with the adult tissue, which contained 10.1 rm-units/mg ofprotein
[6]. The molecular mass of the foetal liver PFK-2 determined by
gel filtration in h.p.l.c. was smaller than for the adult enzyme
(89.1 and 100 kDa respectively), whereas SDS/PAGE gave a
subunit molecular mass of 55 kDa without difference between
both enzymes. In agreement with this observation, mixtures of
foetal and adult enzyme exhibited only one band of 55 kDa. The
discrepancies between these results are unclear, but are probably
related to the three-dimensional structure of the enzymes. In this
sense, it is important to note the unusual behaviour of the
enzyme in ultrafiltration through 30 kDa exclusion membranes,
from which foetal PFK-2 was not retained. Several kinetic
properties of purified foetal and adult liver PFK-2 were com-
pared. The affinities for its two substrates were very similar for
both enzymes. However, foetal liver PFK-2 was about 16-fold
less sensitive than the adult enzyme to inhibition by sn-glycerol
3-phosphate.
Adult liver PFK-2 was inactivated upon incubation with
MgATP and the cyclic AMP-dependent protein kinase [28]
(ratios pH 8.5/pH 6.6 were 1.2 and 3.5 for the dephospho- and
phospho-enzyme respectively). The stoichiometry of the
phosphate incorporation was approx. 1. Foetal liver PFK-2 was
also phosphorylated by cyclic AMP-dependent protein kinase,
exhibiting a stoichiometry of 0.95, but, in contrast with the adult
enzyme, there were no changes in its kinetic properties. In both
cases only one phosphopeptide was evident after phosphorylation
of each enzyme and CNBr digestion. Adult liver was not
phosphorylated by protein kinase C as previously described [9];
by contrast, foetal liver PFK-2 was phosphorylated by protein
kinase C with a stoichiometry of 0.95, but the activity remained
unaffected. In this respecti the foetal fat liver PFK-2 resembles
the myocardial PFK-2, which is phosphorylated by either cyclic
AMP-dependent protein kinase or protein kinase C [10], although
in that report phosphorylation of PFK-2 increased the affinity
for fructose 6-phosphate and the Vmax. Moreover, when foetal
PFK-2 was sequentially phosphorylated by cyclic AMP-de-
pendent protein kinase and protein kinase C, no changes were
observed in the kinetic behaviour of the enzyme.
Western-blot analysis of purified PFK-2 from foetal or adult
liver using a specific antibody raised against the N-terminus of
the adult liver PFK-2 clearly showed that both proteins differ at
least in the N-terminus domain. The staining of the adult enzyme
was at least 6 times that of the foetal protein (Fig. 3). It has been
described [10,11,29] that forms of PFK-2 present in other tissues,
such as heart, muscle and HTC cells, basically differ in the N-
terminus of the protein. The rat skeletal-muscle enzyme is very
similar in structure to the rat liver enzyme, except for the lack of
one peptide (corresponding to nucleotides 14-28) and the lack of
a phosphorylation site by the cyclic AMP-dependent protein
kinase. cDNA analysis of HTC cells predicts a protein in which
the first 32 residues of liver PFK-2 including the cyclic AMP
target sequence have been replaced by a unique N-terminal
decapeptide. Furthermore, the phosphorylation site of the myo-
cardial PFK-2 by cyclic AMP-dependent protein kinase is clearly
different from Ser32, as occurs in the liver enzyme.
Rat liver PFK-2/FBPase-2 contains 10 cysteine residues/
subunit [26]. Three to four of the thiol groups are essential for
catalysis in the kinase reaction [26,27,30,31]. Alkylation of these
cysteine residues located near the kinase domain of PFK-2
results in a decrease in its affinity for fructose 6-phosphate and
a stimulation in Vm.ax. Foetal PFK-2 also contains 3-4 accessible
cysteine residues, although the effect of alkylation on the Vmax is
lower than for the adult enzyme. One possible explanation for
this different behaviour could be related to the fact that alkylation
inhibits FBPase-2 [27], and this activity is very low in the foetal
enzyme. When these reactive cysteine residues were labelled with
iodoacetamide and the carboxyamidomethylated enzyme diges-
ted with CNBr, and these fragments were analysed by reverse-
phase h.p.l.c., only one peptide was labelled in the adult enzyme
[27,30]. Study of the primary sequence of the enzyme subunit
revealed that these cysteine residues were in the N-terminal half
of the subunit at residues 107, 160, 183 and 198 [30]. In agreement
with these results, CNBr digestion of carboxyamidomethylated
adult liver PFK-2 showed nine peptides on monitoring the A280,
and only one naj,aor labelled peak eluted at 8.6 min, which
presumably corresponded to the fragment containing residues
47-277 described by Lively et al. [30]. On the contrary, foetal
PFK-2 showed after digestion with CNBr eight peptides by
monitoring the A280, and two laballed peaks: one eluted at
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8.2 min and a specific peptide eluted at 3.8 min. Comparison of
the CNBr peaks sugested that the ratio of carboxyamido-
methylated residues eluted at 8.6 and 8.3 min was 3:2.6
(adult: foetal peptides), and 1.1 for the specific peak eluted at
3.8 min, for the foetal enzyme. These results suggested that
digestion with CNBr produced different peptides in foetal and
adult liver PFK-2. In addition to alkylation, foetal and adult
PFK-2 were phosphorylated by the cyclic AMP-dependent
protein kinase, followed by digestion with CNBr and h.p.l.c.
analysis. Previous reports [30] identified the cyclic AMP-de-
pendent phosphorylation site of the adult liver enzyme located in
a peptide containing residues 5-43 after treatment with CNBr
which corresponds to Ser32 of the protein. On the other hand,
cyclic AMP-dependent protein kinase and protein kinase C
phosphorylated heart PFK-2 in the same CNBr peptide
(Arg463-Pro479), at residues Ser466 and Thr475 respectively, and
therefore located in the C-terminus region of the protein [15].
Our results showed only one labelled peak for both foetal and
adult PFK-2, but the phosphopeptides were eluted with different
retention times (3.54 and 3.24 min respectively), indicating that
the phosphorylation sites by cyclic AMP-dependent protein
kinase were different and located on two different peptides.
Moreover, sequential phosphorylation by the cyclic AMP-
dependent protein kinase and protein kinase C revealed the
presence of two specific phosphorylation sites in the foetal
enzyme. All of these results suggest that the foetal enzyme of
PFK-2 is distinct from the adult form on the following basis: (a)
differential behaviour on gel filtration; (b) a different peptide
profile after CNBr digestion; (c) the foetal enzyme is phos-
phorylated by the cyclic AMP-dependent protein kinase and by
protein kinase C at two different sites, although without changes
in kinetic properties; and (d) a different immunogenic response
is observed with antibodies recognizing the N-terminal region of
the protein.
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